Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation

被引:11
|
作者
Marcuzzi, Annalisa [2 ]
Crovella, Sergio [2 ]
Monasta, Lorenzo [2 ]
Brumatti, Liza Vecchi [2 ]
Gattorno, Marco [3 ]
Frenkel, Joost [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Pediat, NL-3508 AB Utrecht, Netherlands
[2] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy
[3] Sci Inst G Gaslini, UO Pediat 2, Genoa, Italy
关键词
Mevalonate; statin; aminobisphosphonate; inflammation; cholesterol; PERIODIC FEVER SYNDROME; KAPPA-B ACTIVATION; HYPER-IGD SYNDROME; CELL-DEATH; FARNESYLTRANSFERASE INHIBITORS; HYPERIMMUNOGLOBULINEMIA-D; IN-VITRO; HISTIDINE-DECARBOXYLASE; ISOPRENOID BIOSYNTHESIS; CASPASE ACTIVATION;
D O I
10.2174/138161212803530835
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inflammation is a highly regulated process involved both in the response to pathogens as well as in tissue homeostasis. In recent years, a complex network of proteins in charge of inflammation control has been revealed by the study of hereditary periodic fever syndromes. Most of these proteins belong to a few families and share the capability of sensing pathogen-associated and damage-associated molecular patterns. By interacting with each other, these proteins participate in the assembly of molecular platforms, called inflammasomes, which ultimately lead to the activation of cytokines, to the transcription of inflammatory genes or to the induction of cell apoptosis. Among hereditary periodic fever syndromes, mevalonate kinase deficiency (MKD) is the sole in which the phenotype did not directly associate with a deficiency of these proteins, but with a metabolic defect of the mevalonate pathway, highlighting the importance of this metabolic pathway in the inflammation control. Noteworthy, drugs acting on this pathway can greatly influence the inflammatory response. The modulation of inflammation by mevalonate pathway is of interest, since it may involve mechanisms not directly referable to inflammasomes. MKD provides a model to study these mechanisms and possibly to develop new classes of anti-inflammatory drugs.
引用
收藏
页码:5746 / 5752
页数:7
相关论文
共 50 条
  • [31] Weekly oral alendronate in mevalonate kinase deficiency
    Luca Cantarini
    Antonio Vitale
    Flora Magnotti
    Orso Maria Lucherini
    Francesco Caso
    Bruno Frediani
    Mauro Galeazzi
    Donato Rigante
    Orphanet Journal of Rare Diseases, 8
  • [32] Mevalonate Kinase Deficiency: Diagnostic and Management Challenges
    Choudhary, Puneet Kumar
    Parihar, Vivek
    Satapathy, Jagatshreya
    Bagri, Narendra Kumar
    INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (09): : 937 - 938
  • [33] Molecular and cellular consequences of mevalonate kinase deficiency
    Politiek, Frouwkje A.
    Turkenburg, Marjolein
    Henneman, Linda
    Ofman, Rob
    Waterham, Hans R.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (05):
  • [34] Weekly oral alendronate in mevalonate kinase deficiency
    Cantarini, Luca
    Vitale, Antonio
    Magnotti, Flora
    Lucherini, Orso Maria
    Caso, Francesco
    Frediani, Bruno
    Galeazzi, Mauro
    Rigante, Donato
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [35] Mevalonate kinase deficiency - Evidence for a phenotypic continuum
    Simon, A
    Kremer, HPH
    Wevers, RA
    Scheffer, H
    de Jong, JG
    van der Meer, JWM
    Drenth, JPH
    NEUROLOGY, 2004, 62 (06) : 994 - 997
  • [36] Mevalonate Kinase Deficiency: A Survey of 50 Patients
    Bader-Meunier, Brigitte
    Florkin, Benoit
    Sibilia, Jean
    Acquaviva, Cecile
    Hachulla, Eric
    Grateau, Gilles
    Richer, Olivier
    Farber, Claire Michele
    Fischbach, Michel
    Hentgen, Veronique
    Jego, Patrick
    Laroche, Cecile
    Neven, Benedicte
    Lequerre, Thierry
    Mathian, Alexis
    Pellier, Isabelle
    Touitou, Isabelle
    Rabier, Daniel
    Prieur, Anne-Marie
    Cuisset, Laurence
    Quartier, Pierre
    PEDIATRICS, 2011, 128 (01) : E152 - E159
  • [37] Putative modifier genes in mevalonate kinase deficiency
    Marcuzzi, Annalisa
    Vozzi, Diego
    Girardelli, Martina
    Tricarico, Paola Maura
    Knowles, Alessandra
    Crovella, Sergio
    Vuch, Josef
    Tommasini, Alberto
    Piscianz, Elisa
    Bianco, Anna Monica
    MOLECULAR MEDICINE REPORTS, 2016, 13 (04) : 3181 - 3189
  • [38] Mevalonate kinase deficiency, a metabolic autoinflammatory disease
    van der Burgh, Robert
    ter Haar, Nienke M.
    Boes, Marianne L.
    Frenkel, Joost
    CLINICAL IMMUNOLOGY, 2013, 147 (03) : 197 - 206
  • [39] CHARACTERIZATION OF IMMUNE DEFECTS IN MEVALONATE KINASE DEFICIENCY
    Piscianz, E.
    Marcuzzi, A.
    Valencic, E.
    Tommasini, A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 64 - 65
  • [40] Mevalonate Kinase Deficiency: Diagnostic and Management Challenges
    Puneet Kumar Choudhary
    Vivek Parihar
    Jagatshreya Satapathy
    Narendra Kumar Bagri
    Indian Journal of Pediatrics, 2021, 88 : 937 - 938